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Abstract
Introduction Long-term follow-up after coil embolization
of intracranial aneurysms is mandatory to monitor coil
compacting and aneurysm recurrence. Most centers perform
one digital subtraction angiography (DSA) on follow-up
continuing with time-of-flight magnetic resonance angiog-
raphy (TOF–MRA). This study explores the diagnostic
value of TOF–MRA at 1.5 T versus 3 T compared to DSA.
Materials and methods In 18 patients with 20 aneurysms
treated with coil embolization, TOF–MRA at 1.5 and 3 T
were performed the day before follow-up DSA, the latter
serving as reference. Optimized diagnostic protocols were
applied (1.5 T: 0.78×0.55×0.8 mm, voxel size; acquisition
time (TA), 6.37 min; 3 T: 0.56×0.45×0.65 mm, voxel size;
TA, 3.12 min). Three independent neuroradiologists expe-
rienced in neuroendovascular therapy rated the occlusion
rate (“complete occlusion” vs. “residual neck” vs. “residual
aneurysm”) and compared the two methods subjectively.
Weighted κ statistics were calculated to assess the level of
interobserver agreement.
Results Compared to DSA, TOF–MRA was more sensitive
in detecting neck remnants, with a slight advantage at 3 T.
Regarding artifact load, there are advantages at 1.5 T.
Ratings of the occlusion rate correlated highly between all
observers (r>0.85, p<0.001, respectively). Interobserver
agreement was high in all cases (кw ≈ 0.8, respectively).
Conclusion TOF–MRA is a reliable tool for follow-up
imaging of cerebral aneurysms after endovascular treat-
ment. Our study shows no advantage of TOF–MRA at 3 T
over 1.5 T, when comparable measurement protocols are
applied. TOF–MRA at 1.5 T therefore provides appropriate
information regarding a therapeutic decision.
Keywords Aneurysm . GDC coiling . Follow-up .
Time-of-flight angiography .MR angiography . 3 Tesla
Introduction
Endovascular treatment of intracranial aneurysms today is a
widespread and approved technique, and in a majority of
cases, an alternative to the neurosurgical approach [1–3].
However, recanalization of a cerebral aneurysm treated with
endovascular coil embolization occurs in up to 30% of all
patients and carries a small risk of rebleeding [1–5]. Most
neurointerventional centers therefore currently perform a
post-interventional follow-up digital subtraction angiography
(DSA) after 6 months. If there is a good correlation with a
magnetic resonance angiography (MRA) obtained on the
same occasion, follow-up is continued by MRA at regular
intervals. With regard to current publications, it is discussed
controversially whether TOF–MRA or contrast-enhanced
MRA (CE–MRA) is the superior technique for aneurysm
follow-up [6, 7]. Other authors recommend contrast-
enhanced TOF–MRA to enhance the sensitivity [8, 9].
The purpose of our prospective study was to find out
whether there are significant advantages in performing
TOF–MRA at 3 T as compared to 1.5 T in a routine
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diagnostic setting. The study was performed against the
background of an increasing number of 3 TMR scanners used
in routine diagnostic imaging worldwide [10]. Therefore, we
used optimized but comparable diagnostic sequences that
should be easily reproducible at any MR scanner.
Materials and methods
Patients and aneurysms
Eighteen patients with 20 aneurysms treated with endovas-
cular coil embolization in our department from 2004 until
2006 (nine men; median age, 61 years; range, 29–78 years)
participated in the prospective study. Aneurysm locations
were as follows: anterior communicating artery (Acom),
n=8; internal carotid artery (ICA), n=3; posterior commu-
nicating artery (Pcom), n=4; middle cerebral artery (MCA),
n=1; and basilar artery (BA), n=4. The coils used are
presented in Table 1. Stent remodeling was performed in
eight patients (7× Neuroform 3™, Boston Scientific, Natick,
MA, USA; 1× MicroDriver™, Medtronic, Minneapolis,
MN, USA). Approval of the local ethics committee and
informed patient consent were obtained.
Technique
All patients were admitted for standard 6-months follow-up
DSA, which included a rotational acquisition (AxiomArtis
dBA, Siemens Medical Solutions, Forchheim, Germany).
TOF–MRAwere always performed the day before the DSA
exam.
TOF–MRA at 3 T (Magnetom Trio, Siemens Medical
Solutions, Erlangen, Germany; eight-channel-phased array
head coil) was performed with the following parameters:
repetition time (TR), 23 ms; echo time (TE), 3.68 ms;
image matrix, 448; field of view (FOV), 170×180 mm
(effective voxel size=0.56×0.45×0.65 mm); flip angle,
18°; parallel acquisition technique (PAT, generalized auto-
calibrating partially parallel acquisitions, GRAPPA) factor,
2; and TA, 3.12 min.
TOF–MRA at 1.5 T (Magnetom Sonata, Siemens
Medical Solutions, Erlangen, Germany; CP head coil) was
performed with the following parameters: TR=35 ms; TE=
4.72 ms; image matrix, 384; FOV, 190×210 mm (effective
voxel size=0.78×0.55×0.80 mm); flip angle, 25°; and TA,
6.37 min (no PAT).
Image postprocessing
TOF–MRA data were viewed as three-dimensional (3D)
maximum-intensity projection (MIP) images in free direc-
tions as well as multiplanar reformatted (MPR) thin-slice
images. DSA data included 2D series as well as 3D rotational
angiography (3D-RA)/angiographic computed tomography
images in 3D volume-rendering technique, 3D MIP, and
thin-slice MPR. All image viewing was performed on an
OsiriX™ workstation [11].
Statistical analysis
Three experienced neuroradiologists (K.K., A.M., and
M.K.) independently performed the image viewing and
rating. Firstly, the state of aneurysm occlusion was rated
following a three-step ordinal scale (“complete occlusion”
vs. “residual neck” vs. “residual aneurysm”) [3]. Pearson’s
correlation coefficient was calculated for each pair of
methods in the diagnostic rating. Weighted κ statistics
were calculated to assess interobserver variabilities; a
value above к=0.6 was assumed to represent substantial
agreement [12, 13]. Secondly, a direct method-comparison
questionnaire to achieve a statement of diagnostic superi-
ority vs. equivalence vs. inferiority was completed by each




The cumulative results of the diagnostic viewing performed
by all three raters regarding the occlusion rate are presented
in Table 2. Both 1.5 and 3 T TOF–MRA were more
sensitive than DSA in detecting a neck remnant (14/60 and
16/60 vs. 10/60, respectively). The results regarding the
Table 1 Range of coils used, divided by manufacturer and bioactive
coating.
Bare platinum Bioactive Both
Micrus endovasculara 2 2 1
BostonScientific 7 6 1
Both – – 1
Total 9 8 3
a Renens, Switzerland
Table 2 Cumulative results of the aneurysm occlusion ratings by





Complete occlusion 40 35 33
Residual neck 10 14 16
Residual aneurysm 10 11 11
Overall 60 60 60
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detection of residual aneurysms are nearly the same for all
three methods (11/60 and 11/60 vs. 10/60, respectively). A
consensus rating was not performed. Ratings of the occlusion
rate correlated highly between all observers (r>0.85 and
p<0.001, respectively).
Table 3 shows the results of the κ statistics regarding the
occlusion rate. All observers were tested against each other
regarding every method. Interobserver agreement is very
good for all groups (кw>0.8) [12, 13]. The distribution of
the results in between the observer pairs is homogenous.
Direct comparison
Firstly, a direct comparison of the diagnostic value of each
technique against the other was asked. The cumulative
results are presented graphically in Fig. 1 and show no
trend toward either field strength. Secondly, a direct
comparison of the artifact load was asked. The cumulative
results are displayed in Fig. 2. In only four out of 60
ratings, TOF–MRA at 3 T was scored to be less affected by
artifacts as TOF–MRA at 1.5 T. In contrast, in 20
aneurysms, TOF–MRA at 1.5 T was scored superior. That
trend was coherent when comparing bare platinum versus
bioactive coil packages (subgroup data not shown).
Possible sources of artifacts are presented in the case
figures. A small coil package and a displaced coil cause no
relevant artifact (Fig. 3c,d). A larger coil package causes
impaired flow signal in the adjacent vessel segments
(Figs. 4c and d and 5c and d, closed arrows) but does not
obscure a small neck remnant (Fig. 4c and d, open arrows).
The artifacts caused by a nitinol stent (case shown:
Neuroform 3™, BostonScientific) are acceptable in most
of the cases and only insignificantly pronounced at 3 T
(Fig. 5c and d, open arrow).
Discussion
An aneurysm recurrence rate between 20% and 30% after
endovascular treatment has been reported [3, 4, 14, 15].
The re-treatment rate in the International Subarachnoid
Aneurysm Trial (ISAT) study group was 17.4% [14]. As
currently no guideline exists proposing MRA as the follow-
up method of the first choice, the gold standard in follow-
up diagnostic imaging is still the intraarterial DSA,
associated with an inherent small rate of permanent
neurological deficit [16]. Therefore, in search of an
aneurysm recurrence after endovascular treatment, the most
sensitive and least invasive imaging should be performed. It
has been shown that TOF–MRA is a sensitive and safe
technique regarding coiled aneurysms; some authors have
concluded that it may be even more sensitive than DSA [5,
9, 17–21]. Others recommend CE–MRA or contrast-
enhanced TOF–MRA to raise sensitivity regarding residual
filling and to minimize stent-related artifacts [6, 7, 9, 22,
23]. In our relatively small collective, more neck remnants
were detected in TOF–MRA than in DSA. However, that
finding has no relevance with respect to therapeutical
consequences: A neck remnant would not be treated right
away but rather followed up more closely—by TOF–MRA—
and treated when evolving into a real aneurysm recurrence. If
all follow-up imaging were performed by DSA, the approach
would be the same.
Our study revealed no obvious advantage of TOF–MRA
at 3 T over 1.5 T regarding the diagnostic value of depicting
aneurysm recurrence. There are technical advantages at 3 T,
as there is the much shorter acquisition time due to higher
signal-to-noise ratio and application of parallel imaging
Table 3 Interobserver agreement, measured as kw, achieves substan-





Observers 1 vs. 2 0.81 0.74 0.72
Observers 1 vs. 3 0.78 0.86 0.78
Observers 2 vs. 3 0.87 0.81 0.82
Mean κw 0.82 0.80 0.78
Fig. 1 The diagram shows the cumulative results (three observers and
20 aneurysms, therefore, 60 ratings) of the method comparison
regarding the diagnostic value of TOF–MRA at 1.5 vs. 3 T
Fig. 2 The diagram shows the cumulative results (three observers and
20 aneurysms, therefore, 60 ratings) of the method comparison
regarding the artifact load of TOF–MRA at 1.5 vs. 3 T
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Fig. 3 Follow-up imaging of a
65-year-old male patient with a
history of subarachnoid hemor-
rhage (SAH) and endovascular
therapy of an Acom aneurysm.
Selective DSA reveals coil
compacting and a residual
aneurysm (a unsubtracted, b
subtracted). A stretched coil is
located in the ICA (a arrows).
TOF–MRA (thick-slice MIP and
slice thickness 5 mm, respec-
tively) shows the same finding
regardless of the field strength
(c 1.5 T and d 3 T). No artifacts
occur due to the dislocated coil
Fig. 4 Follow-up imaging of a 59-year-old male patient with a history
of SAH and endovascular therapy of an Acom aneurysm. The DSA
exam was rated as complete occlusion by all observers (a unsubtracted
and b subtracted). TOF–MRA (thick-slice MIP and slice thickness
10 mm, respectively) revealed a very small neck remnant needing no
re-treatment (c 1.5 T; d 3 T, open arrows). Note the coil-related
artifacts in the TOF–MRA at 3 T simulating a stenosis of the left and
actually an occlusion of the right A2 segment (d closed arrows)
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techniques. A higher spatial resolution at a shorter
acquisition time was achieved in the present study applying
3 T, potentially explaining the additional two neck remnants
detected (3 T=16 vs. 1.5 T=14). That was possible despite
the more pronounced susceptibility artifacts at 3 T. The
most important diagnostic impairment in our collective
results from an artificial narrowing of the lumen of adjacent
vessels at 3 T, like that shown earlier in vivo and in vitro
(see Figs. 4d and 5d) [9, 24].
The small subgroup analysis regarding the coil type did
not reveal any differences—the study collective may be
too small. Performing further subgroup analyses regarding
the aneurysm size—and therefore, the amount of implant
material—and the influence of stent-remodeling on the
artifact load would be interesting, especially because of the
observation of less pronounced artifacts with only few implant
material (see Fig. 3). Due to the relatively small study
collective, we did not perform such a subgroup analysis.
Fig. 5 Follow-up imaging of a 32-year-old male patient with a history
of SAH and stent-protected endovascular therapy of a large basilar tip
aneurysm. The DSA exam shows some coil compacting but no
refilling (a unsubtracted and b subtracted). That confirms the TOF–
MRA results (c 1.5 T, d 3 T; thick-slice MIP and slice thickness,
10 mm, respectively). Again, the visualization of the vessels adjacent
to the coil package is impaired at 3 T (d closed arrows). Regardless of
the field strength, only minor artifacts occur due to the NeuroformTM
stent (a, c, and d open arrows)
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However, TOF–MRA at 1.5 T in our study was still
more sensitive in depicting neck remnants than DSA, the
current gold standard. The acquisition time of 6.37 min at
1.5 T is acceptable in clinical neuroimaging if the focus lies
on the cerebral vasculature.
Magnetic field interactions at 3 T have been not
examined for all intracranial implants yet, e.g., some older
aneurysm clips are known not to be suitable for magnetic
resonance imaging (MRI) at 3 T. On the other hand, the
Neuroform™ stent and all platinum coils are [25–27].
Therefore, the group of patients not suitable for 3 T is
relatively small. However, if in doubt regarding the implant
situation, lower field strength should be preferred.
Our results support the conclusions of Urbach et al.
regarding the possibility of only performing DSA if changes
in aneurysm configuration are observed at follow-up TOF–
MRA [5].
Conclusion
The key findings of our study are:
1. TOF-MRA was not inferior compared to DSA and
might therefore replace DSA as the standard method for
aneurysm follow-up.
2. A comparable sequence at 3 T did not translate into
diagnostic benefit compared to 1.5 T.
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